News & Media
A new study published in JCI Insight from Suneil Koliwad MD PhD and his team helps explain why non-obese people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of...
The U.S. Food and Drug Administration has approved Tzield (teplizumab) injection to delay the loss of the body’s own insulin production for pediatric patients aged 8 to 17 years recently diagnosed...
In recognition of her extraordinary scientific career and transformative contributions to immunology, Professor at Diabetes Center, Department of Surgery, Gladstone-UCSF Institute of Genomic...
UCSF Diabetes Center director Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of Medicine at UC San Francisco, has been elected to the National Academy of Sciences — one of the...
Nearly 40 years ago, UCSF scientists ushered in the era of type 1 diabetes prevention. UCSF Diabetes Center is now working to solve the biggest challenges standing between patients and functional...
We had our annual Diabetes Academy, a special event which brings together our researchers, clinicians, supporter, and patients to explore groundbreaking diabetes research and treatments and hear new...
Mark Anderson, MD, PhD accepts the prestigious 2024 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, which recognizes the groundbreaking discoveries in immune tolerance...
Shylaja Srinivasan, MD, discusses the importance of bringing awareness and addressing stigmas related to type 2 diabetes in children. Shylaja Srinivasan is a pediatric endocrinologist who cares for...
Is Ozempic too good to be true? How does it work? Is it safe for everyone? What happens when you stop taking it? Our panel of UCSF experts explore the root causes of excess weight, how weight-loss...
Jeff Bluestone presents "Immune Tolerance: Traveling on the long road towards finding the Holy Grail" at our 20th Year Anniversary Symposium